KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Free Cash Flow: 2017-2025

Historic Free Cash Flow for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$45.8 million.

  • Guardant Health's Free Cash Flow rose 17.18% to -$45.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$262.2 million, marking a year-over-year increase of 4.42%. This contributed to the annual value of -$274.9 million for FY2024, which is 20.41% up from last year.
  • Latest data reveals that Guardant Health reported Free Cash Flow of -$45.8 million as of Q3 2025, which was up 30.59% from -$65.9 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Free Cash Flow peaked at -$25.9 million during Q1 2021, and registered a low of -$135.0 million during Q2 2022.
  • In the last 3 years, Guardant Health's Free Cash Flow had a median value of -$80.2 million in 2023 and averaged -$72.7 million.
  • Per our database at Business Quant, Guardant Health's Free Cash Flow plummeted by 321.98% in 2021 and then skyrocketed by 54.86% in 2024.
  • Guardant Health's Free Cash Flow (Quarterly) stood at -$101.6 million in 2021, then increased by 0.85% to -$100.8 million in 2022, then increased by 17.81% to -$82.8 million in 2023, then fell by 0.70% to -$83.4 million in 2024, then climbed by 17.18% to -$45.8 million in 2025.
  • Its Free Cash Flow was -$45.8 million in Q3 2025, compared to -$65.9 million in Q2 2025 and -$67.1 million in Q1 2025.